Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 76

1.

Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany.

Heigl F, Hettich R, Lotz N, Reeg H, Pflederer T, Osterkorn D, Osterkorn K, Klingel R.

Atheroscler Suppl. 2015 May;18:154-62. doi: 10.1016/j.atherosclerosissup.2015.02.013.

PMID:
25936320
2.

Lipoprotein apheresis for Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease--Additional particular aspects of the Pro(a)LiFe multicenter trial.

Klingel R, Heibges A, Fassbender C.

Atheroscler Suppl. 2015 May;18:35-40. doi: 10.1016/j.atherosclerosissup.2015.02.012.

PMID:
25936302
3.

Clinical benefit of long-term lipoprotein apheresis in patients with severe hypercholesterolemia or Lp(a)-hyperlipoproteinemia with progressive cardiovascular disease.

Heigl F, Hettich R, Lotz N, Reeg H, Pflederer T, Osterkorn D, Osterkorn K, Klingel R.

Clin Res Cardiol Suppl. 2015 Apr;10:8-13. doi: 10.1007/s11789-015-0071-3.

4.

Lipoprotein apheresis results in plaque stabilization and prevention of cardiovascular events: comments on the prospective Pro(a)LiFe study.

Klingel R, Heibges A, Fassbender C.

Clin Res Cardiol Suppl. 2015 Apr;10:46-50. doi: 10.1007/s11789-015-0068-y.

5.

[Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding].

Hoffmann F, Kraft A, Heigl F, Mauch E, Koehler J, Harms L, Kümpfel T, Köhler W, Klingel R, Fassbender C, Schimrigk S.

Nervenarzt. 2015 Feb;86(2):179-86. doi: 10.1007/s00115-014-4239-8. German.

PMID:
25604838
6.

Tryptophan immunoadsorption for the treatment of autoimmune encephalitis.

Köhler W, Ehrlich S, Dohmen C, Haubitz M, Hoffmann F, Schmidt S, Klingel R, Kraft A, Neumann-Haefelin T, Topka H, Stich O, Baumgartner A, Fassbender C.

Eur J Neurol. 2015 Jan;22(1):203-6. doi: 10.1111/ene.12389. Epub 2014 Mar 3.

PMID:
24589025
7.

Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study.

Leebmann J, Roeseler E, Julius U, Heigl F, Spitthoever R, Heutling D, Breitenberger P, Maerz W, Lehmacher W, Heibges A, Klingel R; Pro(a)LiFe Study Group*.

Circulation. 2013 Dec 17;128(24):2567-76. doi: 10.1161/CIRCULATIONAHA.113.002432. Epub 2013 Sep 20.

8.

Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.

Klingel R, Heibges A, Fassbender C.

Atheroscler Suppl. 2013 Jan;14(1):161-5. doi: 10.1016/j.atherosclerosissup.2012.10.024. Review.

PMID:
23357159
9.

[Therapeutic apheresis for autoimmune encephalitis: a nationwide data collection].

Ehrlich S, Fassbender CM, Blaes C, Finke C, Günther A, Harms L, Hoffmann F, Jahner K, Klingel R, Kraft A, Lempert T, Tesch M, Thomsen J, Topka H, Jochim J, Veauthier C, Köhler W.

Nervenarzt. 2013 Apr;84(4):498-507. doi: 10.1007/s00115-012-3710-7. German.

PMID:
23325312
10.

Characteristics of carotid atherosclerotic plaques of chronic lipid apheresis patients as assessed by in vivo high-resolution CMR--a comparative analysis.

Grimm JM, Nikolaou K, Schindler A, Hettich R, Heigl F, Cyran CC, Schwarz F, Klingel R, Karpinska A, Yuan C, Dichgans M, Reiser MF, Saam T.

J Cardiovasc Magn Reson. 2012 Nov 29;14:80. doi: 10.1186/1532-429X-14-80.

11.

Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.

Koziolek MJ, Tampe D, Bähr M, Dihazi H, Jung K, Fitzner D, Klingel R, Müller GA, Kitze B.

J Neuroinflammation. 2012 Apr 26;9:80. doi: 10.1186/1742-2094-9-80.

12.

Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis.

Zolotov D, Wagner S, Kalb K, Bunia J, Heibges A, Klingel R.

J Clin Apher. 2012;27(2):99-105. doi: 10.1002/jca.21200. Epub 2012 Jan 20.

PMID:
22267052
13.

A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis.

Köhler W, Bucka C, Klingel R.

J Clin Apher. 2011 Dec;26(6):347-55. doi: 10.1002/jca.20317. Epub 2011 Nov 17.

PMID:
22095647
14.

Immunoadsorption in patients with chronic inflammatory demyelinating polyradiculoneuropathy with unsatisfactory response to first-line treatment.

Galldiks N, Burghaus L, Dohmen C, Teschner S, Pollok M, Leebmann J, Frischmuth N, Hollinger P, Nazli N, Fassbender C, Klingel R, Benzing T, Fink GR, Haupt WF.

Eur Neurol. 2011;66(4):183-9. doi: 10.1159/000331011. Epub 2011 Sep 3.

PMID:
21912134
15.

[Immunoadsorption for steroid-unresponsive multiple sclerosis-relapses: clinical data of 14 patients].

Mauch E, Zwanzger J, Hettich R, Fassbender C, Klingel R, Heigl F.

Nervenarzt. 2011 Dec;82(12):1590-5. doi: 10.1007/s00115-011-3324-5. German.

PMID:
21667161
16.

Anticoagulation in renal failure is safe and effective.

Klingel R.

Dtsch Arztebl Int. 2011 Feb;108(7):112; author reply 114-5. doi: 10.3238/arztebl.2011.0112a. Epub 2011 Feb 18. No abstract available.

17.

RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration.

Klingel R, Fassbender C, Heibges A, Koch F, Nasemann J, Engelmann K, Carl T, Meinke M, Erdtracht B.

Ther Apher Dial. 2010 Jun;14(3):276-86. doi: 10.1111/j.1744-9987.2010.00807.x.

PMID:
20609179
18.

[Rheopheresis for recurrent sudden hearing loss : therapeutic options for patients refractory to infusion therapy].

Uygun-Kiehne S, Straube R, Heibges A, Klingel R, Davids H.

HNO. 2010 May;58(5):445-51. doi: 10.1007/s00106-009-2004-2. German.

PMID:
20182682
19.

Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives.

Klingel R, Heibges A, Fassbender C.

Atheroscler Suppl. 2009 Dec 29;10(5):129-32. doi: 10.1016/S1567-5688(09)71827-6.

PMID:
20129391
20.

Rheopheresis for sudden sensorineural hearing loss.

Klingel R, Heibges A, Uygun-Kiehne S, Fassbender C, Mösges R.

Atheroscler Suppl. 2009 Dec 29;10(5):102-6. doi: 10.1016/S1567-5688(09)71821-5.

PMID:
20129385
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk